Mesoblast (MESO) Long-Term Deferred Tax (2017 - 2021)

Mesoblast (MESO) posted quarterly Long-Term Deferred Tax of $80.2 million for Q4 2021, little changed year-on-year from $80.1 million in Q4 2020, and little changed on a QoQ basis from $80.2 million in Q3 2021.

Mesoblast (MESO) Long-Term Deferred Tax (2017 - 2021) Analysis & Trends

Mesoblast (MESO) has reported Long-Term Deferred Tax for 5 consecutive years, with $80.2 million the latest figure, recorded in Q4 2021.

  • Quarterly Long-Term Deferred Tax changed 0.11% year-over-year to $80.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $80.2 million (changed 0.11% YoY) and the FY2021 annual result came in at $80.2 million, up 1.35% from the prior year.
  • Long-Term Deferred Tax steadied at $80.2 million in Q4 2021 per MESO's latest filing, from $80.2 million in the prior quarter.
  • Over the last five years, Long-Term Deferred Tax for MESO reached as high as $80.2 million in Q3 2021 and fell as low as $56.6 million in Q2 2018.
  • A 5-year average of $73.2 million and a median of $78.2 million in 2017 frame the typical range for Long-Term Deferred Tax.
  • Annual changes were most pronounced in 2018 — Long-Term Deferred Tax decreased 27.68% — and 2019, when it climbed 21.22%.
  • Year by year, Long-Term Deferred Tax stood at $78.2 million in 2017, then decreased by 23.17% to $60.1 million in 2018, then increased by 21.22% to $72.9 million in 2019, then climbed by 9.97% to $80.1 million in 2020, then gained by 0.11% to $80.2 million in 2021.
  • According to Business Quant data, Long-Term Deferred Tax over the past three periods registered $80.2 million, $80.2 million, and $80.2 million for Q4 2021, Q3 2021, and Q2 2021 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mesoblast 2.08 Bn 1.95 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2021 80.21 Mn
Sep 30, 2021 80.25 Mn
Jun 30, 2021 80.16 Mn
Mar 31, 2021 80.20 Mn
Dec 31, 2020 80.12 Mn
Sep 30, 2020 79.91 Mn
Jun 30, 2020 79.10 Mn
Mar 31, 2020 74.78 Mn
Dec 31, 2019 72.85 Mn
Sep 30, 2019 67.45 Mn
Jun 30, 2019 65.43 Mn
Mar 31, 2019 62.28 Mn
Dec 31, 2018 60.10 Mn
Jun 30, 2018 56.57 Mn
Jun 30, 2017 78.23 Mn